Andrea D Branch | Mount Sinai

About Me

Andrea Branch, PhD, is a Professor in the Department of Medicine, Division of Liver Diseases. The Branch Lab is interested in studying viral hepatitis using both basic and translation research approaches.

Language

English

Position

PROFESSOR | Medicine, Liver Diseases, ASSOCIATE PROFESSOR | Surgery

Research Topics

Antivirals, Bioinformatics, Cancer, Gene Regulation, Hepatitis C Virus, Interferon Resistance, Liver, RNA, Viruses and Virology

Multi-Disciplinary Training Areas

Genetics and Genomic Sciences [GGS], Immunology [IMM]

About Me

Andrea Branch, PhD, is a Professor in the Department of Medicine, Division of Liver Diseases. The Branch Lab is interested in studying viral hepatitis using both basic and translation research approaches.

Language

English

Position

PROFESSOR | Medicine, Liver Diseases, ASSOCIATE PROFESSOR | Surgery

Research Topics

Antivirals, Bioinformatics, Cancer, Gene Regulation, Hepatitis C Virus, Interferon Resistance, Liver, RNA, Viruses and Virology

Multi-Disciplinary Training Areas

Genetics and Genomic Sciences [GGS], Immunology [IMM]

Education

BS, The University of Michigan

MS, The University of California

PhD, The Rockefeller University

, The Rockefeller University

Awards

1976

Rockefeller University Graduate Fellowship

1975

Steinhaus Memorial Teaching Award

1973

Public Health Service Traineeship

Research

We have a strong clinical team that studies real-world outcomes of new direct acting antiviral (DAA) drugs against hepatitis C virus (HCV). New DAAs for HCV are receiving FDA approval and entering clinical practice at a rapid pace, replacing interferon-based therapies with less toxic and more effective regimens that allow a much higher percentage of patients to achieve a sustained virological response (SVR), the positive outcome of HCV treatment. Health care providers need information about how these new medications perform in real world clinical practice. We analyze the short- and long-term impact of new HCV regimens on liver-related outcomes.